Volitionrx (VNRX) Return on Capital Employed (2013 - 2025)
Volitionrx (VNRX) reported Return on Capital Employed of 391.29% for Q4 2025, up 122305.0% on a YoY basis from N/an in Q4 2024, and down 33.72% quarter-over-quarter from 590.4% in Q3 2025.
Volitionrx (VNRX) Return on Capital Employed (2013 - 2025) Analysis & Trends
Volitionrx has reported Return on Capital Employed for 8 years, with the latest figure at 391.29% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed rose 122305.0% year-over-year to 391.29%; the trailing twelve-month figure through Dec 2025 stood at 391.29% (up 122305.0% YoY), and the FY2025 full-year result was 532.76%, up 78105.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 391.29%, down from 590.4% in the prior quarter.
- The five-year high for Return on Capital Employed was 3734.49% in Q2 2025, with the low at 3559.03% in Q1 2023.
- Historically, Return on Capital Employed has averaged 351.25% across 5 years, with a median of 251.97% in 2022.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 401196 bps — and 2025, when it tumbled 397157 bps.
- Volitionrx's Return on Capital Employed stood at 127.45% in 2021, then plunged by 627 bps to 925.96% in 2022, then soared by 72 bps to 256.1% in 2023, then sank by 225 bps to 831.76% in 2024, then surged by 147 bps to 391.29% in 2025.
- The last three Return on Capital Employed figures came in at 391.29% (Q4 2025), 590.4% (Q3 2025), and 3734.49% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Volitionrx | 53.00 Mn | 50.54 Mn | -1.01 Mn | 391.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 391.29% |
| Sep 30, 2025 | 590.40% |
| Jun 30, 2025 | 3,734.49% |
| Mar 31, 2025 | -3,518.64% |
| Dec 31, 2024 | -831.76% |
| Sep 30, 2024 | 172.27% |
| Jun 30, 2024 | 222.55% |
| Mar 31, 2024 | 452.93% |
| Dec 31, 2023 | -256.10% |
| Sep 30, 2023 | -685.05% |
| Jun 30, 2023 | -865.02% |
| Mar 31, 2023 | -3,559.03% |
| Dec 31, 2022 | -925.96% |
| Sep 30, 2022 | -474.13% |
| Jun 30, 2022 | -301.22% |
| Mar 31, 2022 | -247.84% |
| Dec 31, 2021 | -127.45% |
| Sep 30, 2021 | -94.16% |
| Mar 31, 2020 | -123.87% |
| Dec 31, 2019 | -85.75% |